Dyne Therapeutics, Inc. (DYN)
$16.37+2.50%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $2.7B
- Beta
- 1.12
- P/E (TTM)
- -4.62
- Short % float
- 17.35%
- Days to cover
- 5.5
- SI change
- +12.5%
- 1W
- +3.48%
- 1M
- -14.70%
- vs SPY 1W
- +1.92%
- vs SPY 1M
- -16.46%
Industry peers
FMP comparable companies · ranked by market cap
- APGEBUYApogee Therapeutics, Inc.$8.4BBULLQ 60$135.07-0.01%
- CNTACentessa Pharmaceuticals plc$6.3B$40.50
- CGONSELLCG Oncology Inc.$6.1BCRISISQ 25$68.71+1.41%
- MIRMSELLMirum Pharmaceuticals, Inc.$5.0BCRISISQ 36$81.43+0.88%
- TLXSELLTelix Pharmaceuticals Limited$3.7BBEARQ -5$10.88-0.99%
- XENESELLXenon Pharmaceuticals Inc.$3.6BCRISISQ 22$37.57-0.69%
- CELCSELLCelcuity Inc.$3.6BCRISISQ 27$73.62+3.18%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- RARESELLUltragenyx Pharmaceutical Inc.$1.4BRECOVERYQ -6$14.50+2.69%
- AAPGSELLAscentage Pharma Group International$1.4BCRISISQ 3$14.61-2.61%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
